Cordis Europe have announced a collaboration with Volcano Europe, a developer and manufacturer of intravascular ultrasound (IVUS) systems and imaging catheters, that will allow Cordis to assist hospitals in Europe to gain access to Volcano’s IVUS technology.
IVUS is a catheter-based imaging system that allows physicians to acquire very high-resolution images of diseased vessels from inside the artery and facilitates more accurate stent placement.
“Cordis is determined to make IVUS technology more widely available to European physicians and their patients with coronary artery disease,” said Staffan Ternstrom, President, Cordis Europe, Middle East and Africa.
“More than three million patients worldwide have received the CYPHER® Sirolimus-eluting Coronary Stent, whose safety and efficacy is supported by a robust clinical trial program that includes more than 75 clinical studies.”
Now, along with IVUS, physicians have a new and innovative tool to treat the many patients in Europe with coronary artery disease.”
In the past, doctors have used angiograms as a guide to appropriately deploy a stent but as IVUS has improved, doctors and patients are beginning to recognise the advantages of a well-visualised stent placement, particularly in complex lesions. Several recent studies have highlighted the value of IVUS guided stenting for optimal procedural outcomes.
